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Abstract
Optimal pharmacological management during extracorporeal membrane oxygenation (ECMO)
involves more than administering drugs to reverse underlying disease. ECMO is a complex therapy
that should be administered in a goal-directed manner to achieve therapeutic endpoints that allow
reversal of disease and ECMO wean, minimisation of complications (treatment of complications when
they do occur), early interruption of sedation and rehabilitation, maximising patient comfort and
minimising risks of delirium. ECMO can alter both the pharmacokinetics (PK) and pharmacodynamics
(PD) of administered drugs and our understanding of these alterations is still evolving. Based on
available data it appears that modern ECMO circuitry probably has a less significant impact on PK
when compared with critical illness itself. However, these findings need further confirmation in
clinical population PK studies and such studies are underway. The altered PD associated with ECMO is
less understood and more research is indicated. Until robust dosing guidelines become available,
clinicians will have to rely on the principles of drug dosing in critically ill and known PK alterations
induced by ECMO itself. This article summarises the PK alterations and makes preliminary
recommendations on possible dosing approaches.
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